Sign Out
The most frequent (1% or more) adverse effects that may be associated with Atorvastatin therapy, reported in patients participating in controlled clinical studies include: Infections and infestations: nasopharyngitis.
Metabolism and nutrition disorders: hyperglycemia.
Respiratory, thoracic and mediastinal disorders: pharyngolaryngeal pain, epistaxis.
Gastrointestinal disorders: abdominal pain, constipation, diarrhea, dyspepsia, nausea, flatulence.
Musculoskeletal and connective tissue disorders: arthralgia, in extremity, musculoskeletal pain, muscle spasms, myalgia, joint swelling.
Investigations: liver function test abnormal, blood creatine phosphokinase increased.
Psychiatric Disorders: insomnia.
Nervous System Disorders: headache.
General Disorders and Administration Site Conditions: asthenia.
Elevated serum ALT levels have been reported in 1.3% of patients receiving Atorvastatin.
View ADR Monitoring Form
